Total Visits
| Views | |
|---|---|
| Long-Term ... | 9 |
Total Visits Per Month
| February 2022 | March 2022 | April 2022 | May 2022 | June 2022 | July 2022 | August 2022 | |
|---|---|---|---|---|---|---|---|
| Long-Term ... | 0 | 6 | 2 | 1 | 0 | 0 | 0 |
File Visits
| Views | |
|---|---|
| long_term_efficacy_safety_long_acting_complement_c5_inhibitor_ravulizumab_treatment_atypical_hemolytic_uremic_syndrome_adults_2021.pdf | 4 |
| long_term_efficacy_safety_long_acting_complement_c5_inhibitor_ravulizumab_treatment_atypical_hemolytic_uremic_syndrome_adults_2021_material_suplementari.pdf | 2 |
Top country views
| Views | |
|---|---|
| United States | 3 |
| Germany | 2 |
| Belgium | 1 |
| Spain | 1 |
| France | 1 |
| Sweden | 1 |
Top cities views
| Views | |
|---|---|
| Ashburn | 2 |
| Barcelona | 1 |
| Brussels | 1 |
| Buffalo | 1 |
| Karlsruhe | 1 |